drugset / Trial / NCT01475279
A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin
NaSingle-groupOpen-label
Summary
The purpose of this study is to evaluate the potential effect of Dantonic on the steady-state pharmacodynamics and pharmacokinetic of warfarin in healthy subjects and safety of the co-administration of Dantonic and warfarin.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-11
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dantonic | Unknown | 225 mg | — |
| Subject | Warfarin | Small molecule | — | — |
Indications
No indication recorded.